Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta …

F De Crescenzo, GL D'Alò, EG Ostinelli, M Ciabattini… - The Lancet, 2022 - thelancet.com
Background Behavioural, cognitive, and pharmacological interventions can all be effective
for insomnia. However, because of inadequate resources, medications are more frequently …

Sleep and anxiety: From mechanisms to interventions

SL Chellappa, D Aeschbach - Sleep medicine reviews, 2022 - Elsevier
Anxiety is the most common mental health problem worldwide. Epidemiological studies
show that sleep disturbances, particularly insomnia, affect∼ 50% of individuals with anxiety …

Prescribed drugs containing nitrogen heterocycles: an overview

MM Heravi, V Zadsirjan - RSC advances, 2020 - pubs.rsc.org
Heteroatoms as well as heterocyclic scaffolds are frequently present as the common cores in
a plethora of active pharmaceuticals natural products. Statistically, more than 85% of all …

Insomnia disorder: State of the science and challenges for the future

D Riemann, F Benz, RJ Dressle… - Journal of sleep …, 2022 - Wiley Online Library
Insomnia disorder comprises symptoms during night and day that strongly affect quality of
life and wellbeing. Prolonged sleep latency, difficulties to maintain sleep and early morning …

[HTML][HTML] Sleep and the athlete: narrative review and 2021 expert consensus recommendations

NP Walsh, SL Halson, C Sargent, GD Roach… - British journal of sports …, 2021 - bjsm.bmj.com
Elite athletes are particularly susceptible to sleep inadequacies, characterised by habitual
short sleep (< 7 hours/night) and poor sleep quality (eg, sleep fragmentation). Athletic …

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials

E Mignot, D Mayleben, I Fietze, D Leger… - The Lancet …, 2022 - thelancet.com
Background Daytime functioning is impaired in people with insomnia disorder. Currently
available dual orexin receptor antagonists have shown efficacy in insomnia disorder, but do …

[HTML][HTML] Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis

E Hertenstein, E Trinca, M Wunderlin… - Sleep medicine …, 2022 - Elsevier
Almost 70% of patients with mental disorders report sleep difficulties and 30% fulfill the
criteria for insomnia disorder. Cognitive behavioral therapy for insomnia (CBT-I) is the first …

Dealing with sleep problems during home confinement due to the COVID‐19 outbreak: Practical recommendations from a task force of the European CBT‐I Academy

E Altena, C Baglioni, CA Espie, J Ellis… - Journal of sleep …, 2020 - Wiley Online Library
In the current global home confinement situation due to the COVID‐19 outbreak, most
individuals are exposed to an unprecedented stressful situation of unknown duration. This …

Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials

HL Soh, RC Ho, CS Ho, WW Tam - Sleep medicine, 2020 - Elsevier
Objectives Although cognitive behavioural therapy for insomnia (CBT-I) has been
recommended the initial therapy for insomnia, its clinical usage remains limited due to the …

Sleep disturbance and psychiatric disorders

D Freeman, B Sheaves, F Waite, AG Harvey… - The Lancet …, 2020 - thelancet.com
Signs of mental ill health that cut across psychiatric diagnostic categories at high rates are
typically viewed as non-specific occurrences, downgraded in importance and disregarded …